Literature DB >> 16488935

Retinopathy of prematurity.

W V Good, S M Carden.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16488935      PMCID： PMC1856945          DOI： 10.1136/bjo.2005.081166

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  WHO's mission for vision.

Authors: 
Journal:  Afr Health       Date:  1998-07

2.  The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study.

Authors:  William V Good; Robert J Hardy; Velma Dobson; Earl A Palmer; Dale L Phelps; Michelle Quintos; Betty Tung
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

3.  Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.

Authors:  Clare Gilbert; Alistair Fielder; Luz Gordillo; Graham Quinn; Renato Semiglia; Patricia Visintin; Andrea Zin
Journal:  Pediatrics       Date:  2005-04-01       Impact factor: 7.124

4.  Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country.

Authors:  Mai Hong Phan; Phuong Ngoc Nguyen; James D Reynolds
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2003 Jul-Aug       Impact factor: 1.402
  4 in total
  2 in total

1.  Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis.

Authors:  Simona D Nicoară; Anne C Ștefănuţ; Constanta Nascutzy; Gabriela C Zaharie; Laura E Toader; Tudor C Drugan
Journal:  Med Sci Monit       Date:  2016-04-10

2.  Safety and efficacy of 532 nm frequency-doubled Nd-YAG green laser photocoagulation for treatment of retinopathy of prematurity.

Authors:  Simar Rajan Singh; Deeksha Katoch; Sabia Handa; Savleen Kaur; Bruttendu Moharana; Mohit Dogra; Mangat R Dogra
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.